Advancing Survivorship - Day 2 Welcome and New Lung Cancer Treatment Strategies

Advancing Survivorship - Day 2 Welcome and New Lung Cancer Treatment Strategies

Advancing Survivorship - Day 1 Introductions and Heidi's JourneyПодробнее

Advancing Survivorship - Day 1 Introductions and Heidi's Journey

Advancing Survivorship - Day 2 Putting Advocacy Tools Into ActionПодробнее

Advancing Survivorship - Day 2 Putting Advocacy Tools Into Action

Advancing Care for Patients With EGFR Mutation–Positive NSCLC: Precision Medicine StrategiesПодробнее

Advancing Care for Patients With EGFR Mutation–Positive NSCLC: Precision Medicine Strategies

Advancing Survivorship - Day 1 Reflections on Lung Cancer in 2021Подробнее

Advancing Survivorship - Day 1 Reflections on Lung Cancer in 2021

Cancer Treatment & Survivorship Facts & Figures, 2014 - 2015 Key FindingsПодробнее

Cancer Treatment & Survivorship Facts & Figures, 2014 - 2015 Key Findings

Treatment strategies for stage IV lung cancerПодробнее

Treatment strategies for stage IV lung cancer

Advancing Survivorship - Day 1 Patient Navigation and Lung CancerПодробнее

Advancing Survivorship - Day 1 Patient Navigation and Lung Cancer

Advancing Survivorship - Day 2 Supportive Care During SurvivorshipПодробнее

Advancing Survivorship - Day 2 Supportive Care During Survivorship

Faith and an Immunotherapy Clinical Trial: Barry's Lung Cancer StoryПодробнее

Faith and an Immunotherapy Clinical Trial: Barry's Lung Cancer Story

How should we integrate new immunotherapies into treatment strategies for lung cancer?Подробнее

How should we integrate new immunotherapies into treatment strategies for lung cancer?

Treatment Strategies for KRAS+ NSCLC - LCVL 2024Подробнее

Treatment Strategies for KRAS+ NSCLC - LCVL 2024

Patient with Living with Advanced Lung CancerПодробнее

Patient with Living with Advanced Lung Cancer

Advancing lung cancer therapy: from palliative chemotherapy to immunotherapyПодробнее

Advancing lung cancer therapy: from palliative chemotherapy to immunotherapy

Segment 2: Molecular Targets in NSCLCПодробнее

Segment 2: Molecular Targets in NSCLC

Treating Advanced Lung Cancer in Patients Without Driver MutationsПодробнее

Treating Advanced Lung Cancer in Patients Without Driver Mutations

How Can We Advance Equitable Access to Precision Medicine in Lung Cancer Care?Подробнее

How Can We Advance Equitable Access to Precision Medicine in Lung Cancer Care?

Lung Cancer Video Library 2020 - LEVY - Immunotherapy Combinations for Advanced NSCLCПодробнее

Lung Cancer Video Library 2020 - LEVY - Immunotherapy Combinations for Advanced NSCLC

Lung Cancer Survivorship - Post-Treatment SurveillanceПодробнее

Lung Cancer Survivorship - Post-Treatment Surveillance